Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

737 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase II trial of short course fludarabine, mitoxantrone, rituximab followed by ⁹⁰Y-ibritumomab tiuxetan in untreated intermediate/high-risk follicular lymphoma.
Zinzani PL, Tani M, Pulsoni A, De Renzo A, Stefoni V, Broccoli A, Montini GC, Fina M, Pellegrini C, Gandolfi L, Cavalieri E, Torelli F, Scopinaro F, Argnani L, Quirini F, Derenzini E, Rossi M, Pileri S, Fanti S, Baccarani M. Zinzani PL, et al. Among authors: fanti s. Ann Oncol. 2012 Feb;23(2):415-20. doi: 10.1093/annonc/mdr145. Epub 2011 May 2. Ann Oncol. 2012. PMID: 21536660 Free article. Clinical Trial.
Monitoring bulky mediastinal disease with gallium-67, CT-scan and magnetic resonance imaging in Hodgkin's disease and high-grade non-Hodgkin's lymphoma.
Zinzani PL, Zompatori M, Bendandi M, Battista G, Fanti S, Barbieri E, Gherlinzoni F, Rimondi MR, Frezza G, Pisi P, Merla E, Gozzetti A, Canini R, Monetti N, Babini L, Tura S. Zinzani PL, et al. Among authors: fanti s. Leuk Lymphoma. 1996 Jun;22(1-2):131-5. doi: 10.3109/10428199609051740. Leuk Lymphoma. 1996. PMID: 8724540 Clinical Trial.
Predictive role of positron emission tomography (PET) in the outcome of lymphoma patients.
Zinzani PL, Fanti S, Battista G, Tani M, Castellucci P, Stefoni V, Alinari L, Farsad M, Musuraca G, Gabriele A, Marchi E, Nanni C, Canini R, Monetti N, Baccarani M. Zinzani PL, et al. Among authors: fanti s. Br J Cancer. 2004 Aug 31;91(5):850-4. doi: 10.1038/sj.bjc.6602040. Br J Cancer. 2004. PMID: 15266320 Free PMC article.
18F-FDG PET early after radiotherapy in lymphoma patients.
Castellucci P, Zinzani P, Nanni C, Farsad M, Moretti A, Alinari L, Battista G, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Fanti S. Castellucci P, et al. Among authors: fanti s. Cancer Biother Radiopharm. 2004 Oct;19(5):606-12. doi: 10.1089/cbr.2004.19.606. Cancer Biother Radiopharm. 2004. PMID: 15650453
18F-FDG PET in malignant lymphoma: significance of positive findings.
Castellucci P, Zinzani P, Pourdehnad M, Alinari L, Nanni C, Farsad M, Battista G, Tani M, Stefoni V, Canini R, Monetti N, Rubello D, Alavi A, Franchi R, Fanti S. Castellucci P, et al. Among authors: fanti s. Eur J Nucl Med Mol Imaging. 2005 Jul;32(7):749-56. doi: 10.1007/s00259-004-1748-x. Epub 2005 Mar 23. Eur J Nucl Med Mol Imaging. 2005. PMID: 15785956
Potential pitfalls of 18F-FDG PET in a large series of patients treated for malignant lymphoma: prevalence and scan interpretation.
Castellucci P, Nanni C, Farsad M, Alinari L, Zinzani P, Stefoni V, Battista G, Valentini D, Pettinato C, Marengo M, Boschi S, Canini R, Baccarani M, Monetti N, Franchi R, Rampin L, Fanti S, Rubello D. Castellucci P, et al. Among authors: fanti s. Nucl Med Commun. 2005 Aug;26(8):689-94. doi: 10.1097/01.mnm.0000171781.11027.bb. Nucl Med Commun. 2005. PMID: 16000986
Diagnostic role of 18F-FDG PET in gastric MALT lymphoma.
Ambrosini V, Rubello D, Castellucci P, Nanni C, Farsad M, Zinzani P, Alavi A, Tehranipour N, Al-Nahhas A, Fanti S. Ambrosini V, et al. Among authors: fanti s. Nucl Med Rev Cent East Eur. 2006;9(1):37-40. Nucl Med Rev Cent East Eur. 2006. PMID: 16791802
737 results